vs

Side-by-side financial comparison of IRIDEX CORP (IRIX) and Pyxis Tankers Inc. (PXS). Click either name above to swap in a different company.

Pyxis Tankers Inc. is the larger business by last-quarter revenue ($17.0M vs $14.7M, roughly 1.2× IRIDEX CORP).

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

Pyxis Tankers Inc. is an international maritime transport enterprise specializing in seaborne shipping of refined petroleum products and other bulk liquid cargoes. It operates a fleet of modern product tankers, serving global energy markets, with core business covering major trade routes across the Atlantic, Mediterranean and Asia-Pacific regions.

IRIX vs PXS — Head-to-Head

Bigger by revenue
PXS
PXS
1.2× larger
PXS
$17.0M
$14.7M
IRIX

Income Statement — Q4 FY2025 vs Q3 FY2022

Metric
IRIX
IRIX
PXS
PXS
Revenue
$14.7M
$17.0M
Net Profit
$5.3M
Gross Margin
37.2%
Operating Margin
37.2%
Net Margin
31.3%
Revenue YoY
-69.7%
Net Profit YoY
EPS (diluted)
$0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRIX
IRIX
PXS
PXS
Q4 25
$14.7M
Q3 25
$12.5M
Q2 25
$13.6M
Q1 25
$11.9M
Q4 24
$12.7M
Q3 24
$11.6M
Q2 24
$12.6M
Q1 24
$11.8M
Net Profit
IRIX
IRIX
PXS
PXS
Q4 25
Q3 25
$-1.6M
Q2 25
$-994.0K
Q1 25
$-1.7M
Q4 24
$-834.0K
Q3 24
$-1.9M
Q2 24
$-2.7M
Q1 24
$-3.5M
Gross Margin
IRIX
IRIX
PXS
PXS
Q4 25
37.2%
Q3 25
32.1%
Q2 25
34.5%
Q1 25
42.5%
Q4 24
44.0%
Q3 24
37.3%
Q2 24
40.7%
Q1 24
37.9%
Operating Margin
IRIX
IRIX
PXS
PXS
Q4 25
Q3 25
-11.3%
Q2 25
-6.9%
Q1 25
-1.7%
Q4 24
-3.9%
Q3 24
-16.1%
Q2 24
-20.9%
Q1 24
-28.0%
Net Margin
IRIX
IRIX
PXS
PXS
Q4 25
Q3 25
-12.6%
Q2 25
-7.3%
Q1 25
-14.2%
Q4 24
-6.6%
Q3 24
-16.7%
Q2 24
-21.2%
Q1 24
-29.5%
EPS (diluted)
IRIX
IRIX
PXS
PXS
Q4 25
Q3 25
$-0.09
Q2 25
$-0.06
Q1 25
$-0.10
Q4 24
$-0.05
Q3 24
$-0.12
Q2 24
$-0.16
Q1 24
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRIX
IRIX
PXS
PXS
Cash + ST InvestmentsLiquidity on hand
$6.0M
$4.3M
Total DebtLower is stronger
$67.3M
Stockholders' EquityBook value
$54.9M
Total Assets
$29.2M
$138.1M
Debt / EquityLower = less leverage
1.23×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRIX
IRIX
PXS
PXS
Q4 25
$6.0M
Q3 25
$5.6M
Q2 25
$6.8M
Q1 25
$7.2M
Q4 24
$2.4M
Q3 24
$3.9M
Q2 24
$4.1M
Q1 24
$5.4M
Total Debt
IRIX
IRIX
PXS
PXS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
IRIX
IRIX
PXS
PXS
Q4 25
Q3 25
$4.7M
Q2 25
$6.1M
Q1 25
$852.0K
Q4 24
$2.1M
Q3 24
$2.6M
Q2 24
$4.2M
Q1 24
$6.5M
Total Assets
IRIX
IRIX
PXS
PXS
Q4 25
$29.2M
Q3 25
$28.4M
Q2 25
$31.6M
Q1 25
$34.2M
Q4 24
$29.1M
Q3 24
$30.2M
Q2 24
$31.2M
Q1 24
$34.1M
Debt / Equity
IRIX
IRIX
PXS
PXS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRIX
IRIX
PXS
PXS
Operating Cash FlowLast quarter
$2.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
0.45×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRIX
IRIX
PXS
PXS
Q4 25
Q3 25
$-1.2M
Q2 25
$-397.0K
Q1 25
$-1.1M
Q4 24
$-1.2M
Q3 24
$-3.1M
Q2 24
$-1.3M
Q1 24
$-1.6M
Free Cash Flow
IRIX
IRIX
PXS
PXS
Q4 25
Q3 25
$-1.2M
Q2 25
$-410.0K
Q1 25
$-1.2M
Q4 24
$-1.2M
Q3 24
$-3.1M
Q2 24
Q1 24
$-1.7M
FCF Margin
IRIX
IRIX
PXS
PXS
Q4 25
Q3 25
-9.4%
Q2 25
-3.0%
Q1 25
-9.8%
Q4 24
-9.8%
Q3 24
-26.5%
Q2 24
Q1 24
-14.0%
Capex Intensity
IRIX
IRIX
PXS
PXS
Q4 25
Q3 25
0.1%
Q2 25
0.1%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons